Cases started on MDR-TB treatment in Azerbaijan
Azerbaijan: Cases started on MDR-TB treatment was 1,026 in 2024. ▲ Rising
Cases started on MDR-TB treatment in Azerbaijan, 2010–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Azerbaijan recorded 1,026 for cases started on mdr-tb treatment in 2024.
The figure is down 3.0% on the previous year and up 26.0% over ten years.
Over the whole period, cases started on mdr-tb treatment in Azerbaijan peaked at 1,058 in 2023 and was at its lowest, 286, in 2010.
Azerbaijan ranks 20th of 193 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 15 years of available data.
Cases started on MDR-TB treatment in Azerbaijan, year by year
| Year | Value | Change |
|---|---|---|
| 2010 | 286 | — |
| 2011 | 592 | +107.0% |
| 2012 | 404 | -31.8% |
| 2013 | 771 | +90.8% |
| 2014 | 814 | +5.6% |
| 2015 | 827 | +1.6% |
| 2016 | 798 | -3.5% |
| 2017 | 858 | +7.5% |
| 2018 | 821 | -4.3% |
| 2019 | 819 | -0.2% |
| 2020 | 655 | -20.0% |
| 2021 | 964 | +47.2% |
| 2022 | 1,034 | +7.3% |
| 2023 | 1,058 | +2.3% |
| 2024 | 1,026 | -3.0% |
Azerbaijan compared with similar countries
- Azerbaijan's 1,026 is above the median for upper middle income countries, which is 40, 25.6× the median. (57 countries reporting)
- Azerbaijan's 1,026 is above the median for Europe & Central Asia, which is 12.5, 82.1× the median. (48 countries reporting)
Biggest year-on-year movements
Years where Cases started on MDR-TB treatment in Azerbaijan changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2011 | +107.0% | 286 | 592 |
| 2013 | +90.8% | 404 | 771 |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 699 | 286 | 858 | 10 |
| 2020s | 947.4 | 655 | 1,058 | 5 |
Countries ranked near Azerbaijan
More health data for Azerbaijan
- Un projection of annual infant deaths, annual growth rate -1.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1127 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,241 deaths per 1,000 people (2090)
- Number of infants who die before age 1 264 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.72 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0286 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.06 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cases started on mdr-tb treatment in Azerbaijan?
- Cases started on mdr-tb treatment in Azerbaijan was 1,026 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest cases started on mdr-tb treatment recorded in Azerbaijan?
- The highest recorded value was 1,058 in 2023.
- What is the lowest cases started on mdr-tb treatment recorded in Azerbaijan?
- The lowest recorded value was 286 in 2010.
- How does Azerbaijan rank for cases started on mdr-tb treatment?
- Azerbaijan ranks 20th out of 193 countries with data for 2024.
- Is cases started on mdr-tb treatment rising or falling in Azerbaijan?
- Over the last ten years it is up 26.0%. The long-run trend across the full record is rising.
- Where does this Azerbaijan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).